Patents by Inventor Daniel Tartaglia
Daniel Tartaglia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8143592Abstract: Systems, devices, and methods for filling containers with radioactive materials are described. In certain embodiments, the systems comprise a shielding material that substantially defines a chamber and, preferably, substantially blocks radioactivity, a conduit extending through the shielding material into the chamber, and a securing unit that is disposed in the chamber proximal to the conduit and is adapted to receive a container through the conduit.Type: GrantFiled: April 29, 2010Date of Patent: March 27, 2012Assignee: DRAXIMAGE General PartnershipInventor: Daniel Tartaglia
-
Publication number: 20100224791Abstract: Systems and methods are disclosed for producing customized, predictable and reproducible supplies of radioisotopes using, for example, a reactor housing that is fabricated from a radioactive shielding material and has both an internal volume and a surface that comprises an entry port and an exit port, a chromatographic column that is positioned within said internal volume such that a first end of said column is in fluid communication with said entry port and a second end of said column is in fluid communication with said exit port, and a changeable filter module that is disposed external to said reactor housing and in fluid communication with said exit port.Type: ApplicationFiled: March 15, 2010Publication date: September 9, 2010Applicant: DRAXIS HEALTH INC.Inventors: Daniel Tartaglia, Carlo Coppola, Vince Teoli, Alain Bournival
-
Publication number: 20100206425Abstract: Systems, devices, and methods for filling containers with radioactive materials are described. In certain embodiments, the systems comprise a shielding material that substantially defines a chamber and, preferably, substantially blocks radioactivity, a conduit extending through the shielding material into the chamber, and a securing unit that is disposed in the chamber proximal to the conduit and is adapted to receive a container through the conduit.Type: ApplicationFiled: April 29, 2010Publication date: August 19, 2010Applicant: DRAXIS SPECIALITY PHARMACEUTICALS INC.Inventor: Daniel Tartaglia
-
Patent number: 7750328Abstract: Systems, devices, and methods for filling containers with radioactive materials are described. In certain embodiments, the systems comprise a shielding material that substantially defines a chamber and, preferably, substantially blocks radioactivity, a conduit extending through the shielding material into the chamber, and a securing unit that is disposed in the chamber proximal to the conduit and is adapted to receive a container through the conduit.Type: GrantFiled: October 27, 2006Date of Patent: July 6, 2010Assignee: DRAXIMAGE General PartnershipInventor: Daniel Tartaglia
-
Patent number: 7700926Abstract: Systems and methods are disclosed for producing customized, predictable and reproducible supplies of radioisotopes using, for example, a reactor housing that is fabricated from a radioactive shielding material and has both an internal volume and a surface that comprises an entry port and an exit port, a chromatographic column that is positioned within said internal volume such that a first end of said column is in fluid communication with said entry port and a second end of said column is in fluid communication with said exit port, and a changeable filter module that is disposed external to said reactor housing and in fluid communication with said exit port.Type: GrantFiled: July 3, 2007Date of Patent: April 20, 2010Assignee: Draximage General PartnershipInventors: Daniel Tartaglia, Carlo Coppola, Vince Teoli, Alain Guy Bournival
-
Publication number: 20080142743Abstract: Systems, devices, and methods for filling containers with radioactive materials are described. In certain embodiments, the systems comprise a shielding material that substantially defines a chamber and, preferably, substantially blocks radioactivity, a conduit extending through the shielding material into the chamber, and a securing unit that is disposed in the chamber proximal to the conduit and is adapted to receive a container through the conduit.Type: ApplicationFiled: October 27, 2006Publication date: June 19, 2008Applicant: DRAXIS SPECIALTY PHARMACEUTICALS INC.Inventor: Daniel Tartaglia
-
Publication number: 20080093564Abstract: Systems and methods are disclosed for producing customized, predictable and reproducible supplies of radioisotopes using, for example, a reactor housing that is fabricated from a radioactive shielding material and has both an internal volume and a surface that comprises an entry port and an exit port, a chromatographic column that is positioned within said internal volume such that a first end of said column is in fluid communication with said entry port and a second end of said column is in fluid communication with said exit port, and a changeable filter module that is disposed external to said reactor housing and in fluid communication with said exit port.Type: ApplicationFiled: July 3, 2007Publication date: April 24, 2008Applicant: DRAXIS Health Inc.Inventors: Daniel Tartaglia, Carlo Coppola, Vince Teoli, Alain Bournival
-
Publication number: 20070158271Abstract: Systems and methods are disclosed for producing customized, predictable and reproducible supplies of radioisotopes using, for example, a reactor housing that is fabricated from a radioactive shielding material and has both an internal volume and a surface that comprises an entry port and an exit port, a chromatographic column that is positioned within said internal volume such that a first end of said column is in fluid communication with said entry port and a second end of said column is in fluid communication with said exit port, and a changeable filter module that is disposed external to said reactor housing and in fluid communication with said exit port.Type: ApplicationFiled: December 14, 2006Publication date: July 12, 2007Applicant: DRAXIS Health Inc.Inventors: Daniel Tartaglia, Carlo Coppola, Vince Teoli, Alain Guy Bournival
-
Patent number: 5306482Abstract: Benzalkonium chloride and benzethorium chloride are each useful in radiopharmaceutical preparations (optionally in the presence of a polymyxin or a polymyxin derivative) as bacteriostatic agents which are compatible with anti-oxidants.Type: GrantFiled: March 3, 1992Date of Patent: April 26, 1994Assignee: Merck Frosst Canada, Inc.Inventors: Daniel Tartaglia, Richard J. Flanagan
-
Patent number: 5227152Abstract: Benzalkonium chloride and benzethonium chloride are each useful in radiopharmaceutical preparations as bacteriostatic agents which are compatible with anti-oxidants.Type: GrantFiled: December 12, 1991Date of Patent: July 13, 1993Assignee: Merck Frosst Canada, Inc.Inventors: Richard J. Flanagan, Daniel Tartaglia
-
Patent number: 5093105Abstract: Benzalkonium chloride and benzethonium chloride are each useful in radiopharmaceutical preparations as bacteriostatic agents which are compatible with anti-oxidants.Type: GrantFiled: April 9, 1991Date of Patent: March 3, 1992Assignee: Merck Frosst Canada, Inc.Inventors: Richard J. Flanagan, Daniel Tartaglia